Report: AHRQ grant spending slows after Congress appropriated $345 million for fiscal 2026

The Agency for Healthcare Research and Quality, the federal agency focused on evidence and research meant to improve the safety and quality of health care in the United States, has spent less than $15 million on grants in fiscal year 2026 even though Congress appropriated $345 million for the agency, according to CBS News. The report frames the discrepancy as a halt or significant slowdown in grant awards at AHRQ during the current fiscal year.

CBS News reported that the spending gap reflects that AHRQ grantmaking has been limited to a relatively small amount compared with the appropriation Congress set for the year. The agency’s role, as described by CBS News, includes funding research and other efforts intended to generate evidence that can reduce preventable harm in health care settings.

The report comes as congressional appropriations for the year are already on the books, but AHRQ grant spending remains far below the level implied by the $345 million figure. CBS News did not describe, in its summary, the specific internal operational steps or funding instruments responsible for the slowdown, focusing instead on the amount spent on grants relative to the appropriation.

Congress appropriates funding by fiscal year, and an agency’s decision on when and how to award grants can affect the timing of research projects and related contracts. When grant funding is delayed, grantees and research institutions that rely on AHRQ support can face uncertainty about start dates and the ability to plan staffing, data collection, and other work tied to funded projects.

CBS News’ reporting also situates the issue within the broader federal budget process, where agencies must carry out appropriated spending through their procurement and grantmaking systems, subject to review, compliance, and program requirements. The practical question raised by the report is how quickly AHRQ can convert appropriated funds into award activity and whether the slower grant pace will affect the agency’s 2026 research pipeline.

The report’s central comparison is the scale of AHRQ’s fiscal year 2026 appropriation, $345 million, against the amount spent on grants, under $15 million, as of the time of the CBS News publication on July 29, 2026. CBS News did not provide a full accounting in its description of whether the remaining funds are tied up in other categories, reserved for later awards, or constrained by administrative or legal factors.

CBS News’ findings raise questions for lawmakers and stakeholders about AHRQ’s grantmaking pace, the allocation of the fiscal year’s appropriations, and how quickly the agency is expected to translate congressional funding into grant awards. Further clarification would typically require additional detail on AHRQ’s grant obligation and award status across fiscal year 2026, beyond the reported spending total. Without that additional breakdown in the reporting summary, the reasons for the slowdown remain for confirmation through agency records.